Your browser doesn't support javascript.
loading
Selective inhibitors of the Janus kinase Jak3--Are they effective?
Thoma, Gebhard; Drückes, Peter; Zerwes, Hans-Günter.
Affiliation
  • Thoma G; Global Discovery Chemistry, Novartis Institutes for Biomedical Research, 4056 Basel, Switzerland. Electronic address: gebhard.thoma@novartis.com.
  • Drückes P; Center for Proteomic Chemistry, Screening Sciences, Novartis Institutes for Biomedical Research, 4056 Basel, Switzerland.
  • Zerwes HG; Autoimmunity, Transplantation and Inflammation Research, Novartis Institutes for Biomedical Research, 4056 Basel, Switzerland. Electronic address: hans-guenter.zerwes@novartis.com.
Bioorg Med Chem Lett ; 24(19): 4617-4621, 2014 Oct 01.
Article in En | MEDLINE | ID: mdl-25217444
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Protein Kinase Inhibitors / Janus Kinase 3 Limits: Animals / Humans Language: En Journal: Bioorg Med Chem Lett Journal subject: BIOQUIMICA / QUIMICA Year: 2014 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Protein Kinase Inhibitors / Janus Kinase 3 Limits: Animals / Humans Language: En Journal: Bioorg Med Chem Lett Journal subject: BIOQUIMICA / QUIMICA Year: 2014 Document type: Article Country of publication: